Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Retrospective evaluation of the clinical course and outcome following grape or raisin ingestion in dogs (2005-2014): 139 cases.

Reich CF, Salcedo MC, Koenigshof AM, Hopp MM, Walker JM, Schildt JC, Beal MW.

J Vet Emerg Crit Care (San Antonio). 2019 Nov 12. doi: 10.1111/vec.12905. [Epub ahead of print]

PMID:
31714003
2.

Effect of clinical signs, endocrinopathies, timing of surgery, hyperlipidemia, and hyperbilirubinemia on outcome in dogs with gallbladder mucocele.

Jaffey JA, Pavlick M, Webster CR, Moore GE, McDaniel KA, Blois SL, Brand EM, Reich CF, Motschenbacher L, Hostnik ET, Su D, Lidbury JA, Raab O, Carr SV, Mabry KE, Fox-Alvarez W, Townsend S, Palermo S, Nakazono Y, Ohno K, VanEerde E, Fieten H, Hulsman AH, Cooley-Lock K, Dunning M, Kisielewicz C, Zoia A, Caldin M, Conti-Patara A, Ross L, Mansfield C, Lynn O, Claus MA, Watson PJ, Swallow A, Yool DA, Gommeren K, Knops M, Ceplecha V, de Rooster H, Lobetti R, Dossin O, Jolivet F, Papazoglou LG, Pappalardo MCF, Manczur F, Dudás-Györki Z, O'Neill EJ, Martinez C, Gal A, Owen RL, Gunn E, Brown K, Harder LK, Griebsch C, Anfinsen KP, Gron TK, Marchetti V, Heilmann RM, Pazzi P, DeClue AE.

Vet J. 2019 Sep;251:105350. doi: 10.1016/j.tvjl.2019.105350. Epub 2019 Jul 31.

PMID:
31492387
3.

Evaluation of the effects of time, temperature, and specimen storage on in vitro lactate concentrations in healthy dogs.

Reich CF, Bach JF, Walker JM.

Vet Clin Pathol. 2017 Jun;46(2):308-313. doi: 10.1111/vcp.12472. Epub 2017 Mar 27.

PMID:
28346702
4.

Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus.

Ullal AJ, Reich CF 3rd, Clowse M, Criscione-Schreiber LG, Tochacek M, Monestier M, Pisetsky DS.

J Autoimmun. 2011 May;36(3-4):173-80. doi: 10.1016/j.jaut.2011.02.001. Epub 2011 Mar 3.

PMID:
21376534
5.

Use of SYTO 13, a fluorescent dye binding nucleic acids, for the detection of microparticles in in vitro systems.

Ullal AJ, Pisetsky DS, Reich CF 3rd.

Cytometry A. 2010 Mar;77(3):294-301. doi: 10.1002/cyto.a.20833.

6.

The content of DNA and RNA in microparticles released by Jurkat and HL-60 cells undergoing in vitro apoptosis.

Reich CF 3rd, Pisetsky DS.

Exp Cell Res. 2009 Mar 10;315(5):760-8. doi: 10.1016/j.yexcr.2008.12.014. Epub 2008 Dec 30.

PMID:
19146850
7.

Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.

Gasper-Smith N, Crossman DM, Whitesides JF, Mensali N, Ottinger JS, Plonk SG, Moody MA, Ferrari G, Weinhold KJ, Miller SE, Reich CF 3rd, Qin L, Self SG, Shaw GM, Denny TN, Jones LE, Pisetsky DS, Haynes BF.

J Virol. 2008 Aug;82(15):7700-10. doi: 10.1128/JVI.00605-08. Epub 2008 May 28.

8.

In vitro assay of immunostimulatory activities of plasmid vectors.

Jiang W, Reich CF, Pisetsky DS.

Methods Mol Med. 2006;127:55-70. Review.

PMID:
16988446
9.

The extracellular release of HMGB1 during apoptotic cell death.

Bell CW, Jiang W, Reich CF 3rd, Pisetsky DS.

Am J Physiol Cell Physiol. 2006 Dec;291(6):C1318-25. Epub 2006 Jul 19.

10.

The binding of sera of patients with SLE to bacterial and mammalian DNA.

Hamilton KJ, Schett G, Reich CF 3rd, Smolen JS, Pisetsky DS.

Clin Immunol. 2006 Feb-Mar;118(2-3):209-18. Epub 2005 Nov 18.

PMID:
16298553
11.

The release of microparticles by apoptotic cells and their effects on macrophages.

Distler JH, Huber LC, Hueber AJ, Reich CF 3rd, Gay S, Distler O, Pisetsky DS.

Apoptosis. 2005 Aug;10(4):731-41.

PMID:
16133865
12.
13.

The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles.

Distler JH, Jüngel A, Huber LC, Seemayer CA, Reich CF 3rd, Gay RE, Michel BA, Fontana A, Gay S, Pisetsky DS, Distler O.

Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2892-7. Epub 2005 Feb 8.

14.

Release of DNA from dead and dying lymphocyte and monocyte cell lines in vitro.

Choi JJ, Reich CF 3rd, Pisetsky DS.

Scand J Immunol. 2004 Jul-Aug;60(1-2):159-66.

15.

Induction of immune activation by a novel immunomodulatory oligonucleotide without thymocyte apoptosis.

Jiang W, Reich CF 3rd, You D, Kandimalla E, Agrawal S, Pisetsky DS.

Biochem Biophys Res Commun. 2004 May 21;318(1):60-6.

PMID:
15110753
16.
17.

The use of fluorometric assays to assess the immune response to DNA in murine systemic lupus erythematosus.

Björkman L, Reich CF, Pisetsky DS.

Scand J Immunol. 2003 Jun;57(6):525-33.

18.

Role of macrophages in the generation of circulating blood nucleosomes from dead and dying cells.

Jiang N, Reich CF 3rd, Pisetsky DS.

Blood. 2003 Sep 15;102(6):2243-50. Epub 2003 May 29.

PMID:
12775567
19.

Effect of cytofectins on the immune response of murine macrophages to mammalian DNA.

Zhu FG, Reich CF, Pisetsky DS.

Immunology. 2003 Jun;109(2):255-62.

20.

The expression of plasma nucleosomes in mice undergoing in vivo apoptosis.

Jiang N, Reich CF 3rd, Monestier M, Pisetsky DS.

Clin Immunol. 2003 Feb;106(2):139-47.

PMID:
12672404
21.

Inhibition of murine dendritic cell activation by synthetic phosphorothioate oligodeoxynucleotides.

Zhu FG, Reich CF, Pisetsky DS.

J Leukoc Biol. 2002 Dec;72(6):1154-63.

PMID:
12488497
22.

Inhibition of murine macrophage nitric oxide production by synthetic oligonucleotides.

Zhu FG, Reich CF, Pisetsky DS.

J Leukoc Biol. 2002 Apr;71(4):686-94.

PMID:
11927656
23.

The role of surface ig binding in the activation of human B cells by phosphorothioate oligodeoxynucleotides.

Liang H, Reich CF, Pisetsky DS, Lipsky PE.

Scand J Immunol. 2001 Dec;54(6):551-63.

24.

The role of cpg sequences in the induction of anti-DNA antibodies.

Pisetsky DS, Wenk KS, Reich CF 3rd.

Clin Immunol. 2001 Aug;100(2):157-63.

PMID:
11465944
25.
26.

Inhibition of murine macrophage IL-12 production by natural and synthetic DNA.

Pisetsky DS, Reich CF.

Clin Immunol. 2000 Sep;96(3):198-204.

PMID:
10964537
27.

The role of cell surface receptors in the activation of human B cells by phosphorothioate oligonucleotides.

Liang H, Reich CF, Pisetsky DS, Lipsky PE.

J Immunol. 2000 Aug 1;165(3):1438-45.

28.

In vitro assay of immunostimulatory activities of plasmid vectors.

Reich CF, Pisetsky DS.

Methods Mol Med. 2000;29:173-84. doi: 10.1385/1-59259-688-6:173.

PMID:
21374319
29.

Influence of backbone chemistry on immune activation by synthetic oligonucleotides.

Pisetsky DS, Reich CF 3rd.

Biochem Pharmacol. 1999 Dec 15;58(12):1981-8.

PMID:
10591154
30.

The influence of lipofectin on the in vitro stimulation of murine spleen cells by bacterial DNA and plasmid DNA vectors.

Pisetsky DS, Reich CF 3rd.

J Interferon Cytokine Res. 1999 Oct;19(10):1219-26.

PMID:
10547162
31.

The binding of anti-DNA antibodies to phosphorothioate oligonucleotides in a solid phase immunoassay.

Pisetsky DS, Reich CF 3rd.

Mol Immunol. 1998 Dec;35(18):1161-70.

PMID:
10199390
32.

Immunostimulatory properties of genomic DNA from different bacterial species.

Neujahr DC, Reich CF, Pisetsky DS.

Immunobiology. 1999 Feb;200(1):106-19.

PMID:
10084699
33.

The influence of base sequence on the immunological properties of defined oligonucleotides.

Pisetsky DS, Reich CF 3rd.

Immunopharmacology. 1998 Nov;40(3):199-208.

PMID:
9858063
34.

Activation of human B cells by phosphorothioate oligodeoxynucleotides.

Liang H, Nishioka Y, Reich CF, Pisetsky DS, Lipsky PE.

J Clin Invest. 1996 Sep 1;98(5):1119-29.

35.

The influence of DNA size on the binding of anti-DNA antibodies in the solid and fluid phase.

Pisetsky DS, Reich CF.

Clin Immunol Immunopathol. 1994 Sep;72(3):350-6.

PMID:
7520375
37.

Constraints on communication in classrooms for the deaf.

Matthews TJ, Reich CF.

Am Ann Deaf. 1993 Mar;138(1):14-8.

PMID:
8484347
38.

IgG binding of monoclonal anti-nuclear antibodies from MRL-lpr/lpr mice.

Pisetsky DS, Darwin BS, Reich CF.

Immunology. 1990 Dec;71(4):586-91.

39.

Selective recognition of DNA antigenic determinants by murine monoclonal anti-DNA antibodies.

Wu DP, Gilkeson GS, Armitage J, Reich CF, Pisetsky DS.

Clin Exp Immunol. 1990 Oct;82(1):33-7.

40.

In vitro autoantibody production by normal adult and cord blood B cells.

Pisetsky DS, Jelinek DF, McAnally LM, Reich CF, Lipsky PE.

J Clin Invest. 1990 Mar;85(3):899-903.

41.

Analysis of autoantibody binding to different regions of the human La antigen expressed in recombinant fusion proteins.

St Clair EW, Pisetsky DS, Reich CF, Keene JD.

J Immunol. 1988 Dec 15;141(12):4173-80.

PMID:
2461985
42.

Quantitative immunoassay of anti-La antibodies using purified recombinant La antigen.

St Clair EW, Pisetsky DS, Reich CF, Chambers JC, Keene JD.

Arthritis Rheum. 1988 Apr;31(4):506-14.

PMID:
3128988
43.

Establishment and characterization of a cell line (SS78) from a human renal cell carcinoma.

Shrivastav S, Sharief Y, Day J, Reich CF, Bonar RA.

In Vitro. 1981 Dec;17(12):117-24.

PMID:
7319533
44.

Clastogenic effect of 4-nitroquinoline-1-oxide on swine urothelial cells in culture.

Sharief Y, Reich CF 3rd, Bonar RA.

Invest Urol. 1980 Mar;17(5):390-4.

PMID:
6766912
45.

Polyploidy in mammalian urothelial cells.

Sharief Y, Reich CF 3rd, Bonar RA.

Urol Res. 1980;8(3):153-61.

PMID:
7423695
46.

Canine urinary bladder epithelial cells: preparation for cell culture by enzyme dispersion.

Bonar RA, Reich CF 3rd, Sharief Y.

Urol Res. 1977;5(2):87-94.

PMID:
195376
47.

In vitro culture of epithelial cells derived from urogenital tissues.

Stone KR, Paulson DF, Bonar RA, Reich CF 3rd.

Urol Res. 1975;2(4):149-53. No abstract available.

PMID:
1170668
48.

Effects of vasoactive agents on isolated human umbilical arteries and veins.

Altura BM, Malaviya D, Reich CF, Orkin LR.

Am J Physiol. 1972 Feb;222(2):345-55. No abstract available.

PMID:
4400488

Supplemental Content

Loading ...
Support Center